Guangxi LiuYao Group Co., Ltd (SHA:603368)
17.02
-0.17 (-0.99%)
Apr 16, 2026, 10:09 AM CST
Guangxi LiuYao Group Market Cap
Guangxi LiuYao Group has a market cap or net worth of 6.69 billion as of April 15, 2026. Its market cap has decreased by -10.09% in one year.
Market Cap
6.69B
Enterprise Value
8.95B
Revenue
20.95B
Ranking
n/a
PE Ratio
8.69
Stock Price
17.02
Market Cap Chart
Since December 4, 2014, Guangxi LiuYao Group's market cap has increased from 4.25B to 6.69B, an increase of 57.46%. That is a compound annual growth rate of 4.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 6.69B | -3.52% |
| Dec 31, 2025 | 6.93B | -2.61% |
| Dec 31, 2024 | 7.12B | 4.58% |
| Dec 29, 2023 | 6.81B | 0.66% |
| Dec 30, 2022 | 6.76B | -1.81% |
| Dec 31, 2021 | 6.89B | -11.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Pharmaceuticals Holding | 57.54B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 35.59B |
| Jointown Pharmaceutical Group | 26.93B |
| China National Medicines Corporation | 22.03B |
| Liaoning Cheng Da | 17.78B |
| China Meheco Group | 16.68B |
| China National Accord Medicines Corporation | 13.70B |
| Qingdao Baheal Medical INC. | 13.60B |